insights_auto
Why is ORX up 5.76%?
Dive Deeperchevron_right
ORX:STO
Orexo AB
SEKÂ 0.90
arrow_upward
+5.76%(+0.049) 1D
Nov 17, 5:29:55 PM GMT+1 · SEK
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ORX...
Open
SEKÂ 0.83
High
SEKÂ 0.98
Low
SEKÂ 0.83
Mkt. cap
315.79M
Avg. vol.
790.03K
Volume
719.07K
P/E ratio
0.07
52-wk high
SEKÂ 22.55
52-wk low
SEKÂ 0.80
EPS
SEKÂ 13.61
Shares outstanding
35.13M
No. of employees
55
Open
SEKÂ 0.83
High
SEKÂ 0.98
Low
SEKÂ 0.83
Mkt. cap
315.79M
Avg. vol.
790.03K
Volume
719.07K
P/E ratio
0.07
52-wk high
SEKÂ 22.55
52-wk low
SEKÂ 0.80
EPS
SEKÂ 13.61
Shares outstanding
35.13M
No. of employees
55
News stories
From web sources and news partners
BigGo Finance
·
9 minutes ago
Wall Street Split on 2027 S&P 500 Outlook: Wells Fargo's 8,200 vs. Morgan Stanley's 8,700
TV News Check
·
39 minutes ago
Dow Drops 849, Nasdaq Sinks 181, S&P 500 Falls 76
marketscreener.com
·
59 minutes ago
S&P 500 Pullback Extends to Fourth Day Ahead of Nvidia's Earnings
www.tmgm.com
·
5 minutes ago
NSA outage sends Dow Jones Industrial Average lower before Nvidia beats
Profile
Orexo is a Swedish pharmaceutical company that develops improved pharmaceuticals based on innovative formulation technologies that meet large medical needs. Through presence its in the US market, drugs and digital therapies are commercialized to treat opioid use disorder and adjacent diseases. Products targeting other therapeutic areas are developed and commercialized worldwide with partners. Wikipedia
About Orexo AB
CEONikolaj Sørensen
Employees55
Founded1995
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Websiteorexo.com